HOME > Chargé d'Affaires News
中文
Notice for China-bound Travelers
2022-12-29 01:48

Starting from January 8, 2023, COVID-19 will be managed as a Class B infectious disease in China, and border control measures will be adjusted accordingly. China-bound travelers are advised to read the following information on the adjustment to facilitate traveling:


1.Nucleic Acid Test

Travelers are required to take nucleic acid test within 48 hours before flight departure, and can only take flight when the test result is negative.

2.Health Code

Travelers are no longer required to obtain health code from The Office of the Chargé d’Affaires of the People's Republic of China in the Republic of  Lithuania before departure.

3.Health Declaration to China Customs

Travelers need to declare the negative test result to China Customs by filling the Health Declaration Form either on Wechat mini-program of China Customs (scan the QR code below),or at https://htdecl.chinaport.gov.cn/htdeclweb/home/pages/healthDeclare/declare.html, or via the China Customs APP.

4.Entry Inspection

There will be no nucleic acid test when travelers enter China, and no quarantine for those whose health declaration and entry inspection produce normal results. In case of a positive test result or any symptoms such as fever detected by China Customs, travelers will take an antigen test. Those who test positive in the test will need to self-quarantine.

The above measures will be effective for all passengers arriving in China after 00:00 am (included) on January 8, 2023.


Given the ongoing pandemic, the above adjustments do not mean the easing of disease control. Travelers are advised to take primary responsibility for their health, and use precautionary measures for self-protection. The Chinese government will continue to monitor the latest trends of the pandemic, and adjust the disease control practices accordingly to facilitate entry and exit of personnel.


Suggest To A Friend
  Print
The Office of the Chargé d'Affaires of the People's Republic of China in the Republic of Lithuania All Rights Reserved